文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

成人呼吸衰竭接受静脉-静脉体外膜氧合支持期间的神经损伤:体外生命支持组织数据库分析

Neurologic Injury in Adults Supported With Veno-Venous Extracorporeal Membrane Oxygenation for Respiratory Failure: Findings From the Extracorporeal Life Support Organization Database.
PubMed 文献 · Crit Care Med · 2017-01-01
一句话结论接受静脉-静脉体外膜氧合(VV-ECMO)的成人呼吸衰竭患者中约7.1%发生神经损伤,以颅内出血最常见,合并神经损伤者院内死亡率高达75.8%。

该研究回顾性分析体外生命支持组织(ELSO)数据库1992-2015年间350个国际中心收治的4,988例因呼吸衰竭接受VV-ECMO的成人(≥18岁)患者,神经损伤定义为ECMO支持期间发生脑死亡、癫痫发作、卒中或颅内出血。356例(7.1%)共报告426次神经并发症,包括颅内出血181例(42.5%)、脑死亡100例(23.5%)、卒中85例(19.9%)、癫痫发作60例(14.1%)。合并中枢神经系统并发症者院内死亡率显著高于无并发症者(75.8% vs 37.8%,p<0.001),且随损伤类型而异:颅内出血79.6%、卒中68.2%、癫痫发作50%。ECMO前心脏骤停、ECMO期间连续静脉-静脉血液滤过及高胆红素血症与神经损伤风险增加相关。

要点

  • VV-ECMO成人呼吸衰竭患者神经损伤发生率7.1%(356/4,988),其中颅内出血最常见(181例,占42.5%)。
  • 合并神经损伤者院内死亡率75.8%,显著高于无神经损伤者的37.8%(p<0.001)。
  • 不同神经损伤类型死亡率:颅内出血79.6%、卒中68.2%、癫痫发作50%。
  • ECMO前心脏骤停、ECMO期间连续静脉-静脉血液滤过及高胆红素血症与神经损伤风险增加相关。
  • 作者认为未来研究应评估抗凝管理及脑与ECMO的相互作用,以减少这些危及生命的事件。

适用人群与场景

  • 成人(≥18岁)因呼吸衰竭接受静脉-静脉体外膜氧合(VV-ECMO)支持的患者。
  • 数据来源为1992-2015年间350个国际体外生命支持组织(ELSO)中心上报的病例。

诊断标准与关键阈值

  • 神经损伤定义为ECMO支持期间发生脑死亡、癫痫发作、卒中或颅内出血。

研究设计与关键结果

  • 研究类型:回顾性分析ELSO数据注册库,纳入4,988例成人呼吸衰竭VV-ECMO患者,中位年龄46岁(四分位距32-58)。
  • 神经损伤总体发生率7.1%(356例),共报告426次神经并发症:颅内出血181例(42.5%)、脑死亡100例(23.5%)、卒中85例(19.9%)、癫痫发作60例(14.1%)。
  • 合并中枢神经系统并发症者院内死亡率75.8%,无并发症者37.8%(p<0.001)。
  • 不同神经损伤类型死亡率:颅内出血79.6%、卒中68.2%、癫痫发作50%。
  • 多变量逻辑回归显示,ECMO前心脏骤停、ECMO期间连续静脉-静脉血液滤过及高胆红素血症与神经损伤风险增加相关。

证据类型、等级与局限

  • 证据类型:回顾性分析ELSO数据注册库。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为未来研究应评估抗凝管理以及脑与ECMO的相互作用,以减少这些危及生命的事件。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To assess in-hospital neurologic (CNS) complications in adult patients undergoing veno-venous extracorporeal membrane oxygenation for respiratory failure.

DESIGN: Retrospective analysis of the Extracorporeal Life Support Organization's data registry.

SETTING: Data reported to Extracorporeal Life Support Organization from 350 international extracorporeal membrane oxygenation centers during 1992-2015.

PATIENTS: Adults (≥ 18 yr old) supported with veno-venous extracorporeal membrane oxygenation for respiratory failure.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We included 4,988 adults supported with veno-venous extracorporeal membrane oxygenation for respiratory failure. Neurologic injury was defined as brain death, seizures, stroke, and intracranial hemorrhage occurring during extracorporeal membrane oxygenation support. We used multivariable logistic regression to explore patient and extracorporeal membrane oxygenation factors associated with neurologic injury. Median age of the study cohort was 46 (interquartile range, 32-58). Four hundred twenty-six neurologic complications were reported in 356 patients (7.1%), and included 181 intracranial hemorrhage (42.5%), 100 brain deaths (23.5%), 85 stroke (19.9%), and 60 seizure events (14.1%). In-hospital mortality was significantly higher for those with CNS complications (75.8% vs 37.8%; p < 0.001) and varied by type of CNS injury; mortality was 79.6% in patients with intracranial hemorrhage, 68.2% in patients with stroke, and 50% in patients with seizures. Pre-extracorporeal membrane oxygenation cardiac arrest, continuous veno-venous hemofiltration, and hyperbilirubinemia during extracorporeal membrane oxygenation were associated with increased odds of neurologic injury.

CONCLUSIONS: Approximately 7% of adults supported with veno-venous extracorporeal membrane oxygenation for respiratory failure had neurologic injury. Intracranial hemorrhage was the most frequent type, and survival for patients with neurologic injury was poor. Future investigations should evaluate anticoagulation management as well as brain/extracorporeal membrane oxygenation interaction to reduce these life-threatening events.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Lorusso R, Gelsomino S, Parise O, et al. Neurologic Injury in Adults Supported With Veno-Venous Extracorporeal Membrane Oxygenation for Respiratory Failure: Findings From the Extracorporeal Life Support Organization Database. Crit Care Med. 2017. PMID: 28538440. doi:10.1097/CCM.0000000000002502

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。